DoD Lupus, Idea Award


Funding Opportunity ID: 327409
Opportunity Number: W81XWH-20-LRP-IA
Opportunity Title: DoD Lupus, Idea Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.420
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-AMRAA
Agency Name: Department of Defense
Dept. of the Army — USAMRAA
Posted Date: May 29, 2020
Close Date: Sep 23, 2020
Last Updated Date: May 29, 2020
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $1,800,000
Expected Number of Awards: 6
Description: The LRP Idea Award supports innovative, high-risk/high-reward research that could ultimatelylead to a critical discovery or major advancement relevant to lupus. This award mechanismsupports studies that have the potential to reveal entirely new avenues for investigation. Theapplication must describe how the new idea will enhance the existing knowledge of lupus ordevelop an innovative and novel course of investigation. The Idea Award is not intended tosupport an incremental progression of an already established research project. Researchcompleted through an Idea Award may generate sufficient preliminary data to enable thePrincipal Investigator (PI) to prepare an application for future research. Inclusion ofpreliminary data is not required.The following are important aspects of the Idea Award: Innovation: Innovative research may introduce a new paradigm, look at existing problemsfrom new perspectives, or exhibit other highly creative qualities. It is the responsibility of thePI to clearly and explicitly describe how the proposed research is innovative and will lead tonovel avenues of investigation in lupus research. Impact: The proposed research, if successful, should impact an area of paramountimportance in lupus disease. Applications should clearly and explicitly describe the potentialimpact(s) of the proposed study for individuals living with lupus and to convey its level ofsignificance. Research that represents an incremental advancement on previously publishedwork is not considered impactful. Research Strategy: The scientific rationale and experimental methodology shoulddemonstrate critical understanding and in-depth analysis of lupus. Experimental strategiesmay be novel or may be based on strong rationale derived from a literature review. Focus Areas: The proposed research must address at least one of the FY20 LRP FocusAreas.Clinical trials are not allowed under this Program Announcement.The proposed research must be relevant to active duty Service members, Veterans, militarybeneficiaries, and/or the American public.The types of awards made under the Program Announcement will be assistance agreements. An assistance agreement is appropriate when the Federal Government transfers a “thing of value” to a “state, local government,” or “other recipient” to carry out a public purpose of support or stimulation authorized by a law of the United States instead of acquiring property or service for the direct benefit and use of the U.S. Government. An assistance agreement can take the form of a grant or cooperative agreement. The level of involvement on the part of the Department of Defense (DoD) during project performance is the key factor in determining whether to award a grant or cooperative agreement. If “no substantial involvement” on the part of the funding agency is anticipated, a grant award will be made (31 USC 6304). Conversely, if substantial involvement on the part of the funding agency is anticipated, a cooperative agreement will be made (31 USC 6305), and the award will identify the specific substantial involvement. Substantial involvement may include, but is not limited to, collaboration, participation, or intervention in the research to be performed under the award. The award type, along with the start date, will be determined during the negotiation process.The anticipated total costs budgeted for the entire period of performance for an FY20 LRP Idea Award will not exceed $300,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards will be made no later than September 30, 2021. For additional information refer to Section II.F.1, Federal Award Notices.The CDMRP expects to allot approximately $1.80M to fund approximately six Idea Award applications. Funding of applications received is contingent upon the availability of Federal funds for this program as well as the number of applications received, the quality and merit of the applications as evaluated by scientific and programmatic review, and the requirements of the Government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY20 funding opportunity will be funded with FY20 funds, which will expire for use on September 30, 2026.
Version: 1

Visit the Official Webpage For More Details on DoD Lupus, Idea Award


Please enter your comment!
Please enter your name here